NYSE:QGENLife Sciences
Does Qiagen's (QGEN) Bigger Dividend and Governance Shift Signal a New Capital Allocation Playbook?
In May 2026, QIAGEN N.V. proposed a 40% increase in its annual cash dividend to US$0.35 per share for approval at the June 24, 2026 Annual General Meeting, while also announcing plans to appoint co-founder and former CEO Dr. Metin Colpan as Honorary Chairman after he steps down from the Supervisory Board.
The combination of a higher dividend, expanded shareholder return authorizations, and ongoing Supervisory Board renewal underscores how QIAGEN is pairing governance refreshment with a...